Clinical Trial Update: Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating a combination of sorafenib with carboplatin and paclitaxel in patients with solid tumors; study sponsored by Bayer and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Neoplasms | Phase 1 | Status: COMPLETED